… tolerability of tranexamic acid in conditions amenable to antifibrinolytic therapy and briefly
… In large, randomized controlled trials, tranexamic acid generally significantly reduced …

… outcomes of the popular antifibrinolytic drug tranexamic acid (TXA) … Antifibrinolytic agents
are widely used in the management of … Among antifibrinolytic medications are the small protein …

… In conclusion, tranexamic acid seems to be an effective treatment for … antifibrinolytic trial),
has now been established to determine the effect of early administration of tranexamic acid on …

… Human plasminogen contains structures, called lysine-binding sites, which are of importance
not only for its interaction with antifibrinolytic amino acids such as tranexamic acid but also …

… experimental work suggest antifibrinolytic therapy should be … asm for routine delivery of
tranexamic acid (TXA) to severely … selective use of an antifibrinolytic in mature trauma systems. …

… Antifibrinolytics, such as tranexamic acid (TXA) are used for prophylaxis and … activation
tranexamic acid (TXA) and/or ε‑aminocapronic acid (ΕΑΧΑ) have been used in the treatment of HF…

… 7 Antifibrinolytic drugs are often used as part of the blood conservation strategy during … 8
Tranexamic acid (TXA) and ε-aminocaproic acid (EACA) act by reversibly blocking the lysine …

… TXA as an antifibrinolytic treatment applied in a perioperative setting has strong pharmacological
and clinical grounds. Although there are other situations in which the use of TXA is …

… The finding in the present study that local antifibrinolytic treatment significantly reduced the
incidence of postoperative bleeding supports the view that fibrinolysis in the oral activity is an …

… Exposure to the extracorporeal circuit activates the fibrinolytic system and causes platelet
dysfunction, thus in addition to its’ antifibrinolytic activity tranexamic acid helps preserve …